Key lipogenesis genes (SREBP1c, ACLY, ACC, FASN, and SCD1) are directly regulated by LXR, and their expression levels upon 1E5 treatment are shown to be downregulated in breast cancers [19]. The gene discussed is FASN; the disease is breast cancer.